Risk factors for comorbid oppositional defiant disorder in attention-deficit/hyperactivity disorder

被引:0
|
作者
Siri D. S. Noordermeer
Marjolein Luman
Wouter D. Weeda
Jan K. Buitelaar
Jennifer S. Richards
Catharina A. Hartman
Pieter J. Hoekstra
Barbara Franke
Dirk J. Heslenfeld
Jaap Oosterlaan
机构
[1] Vrije Universiteit Amsterdam,Clinical Neuropsychology Section
[2] Leiden University,undefined
[3] Radboud University Medical Center,undefined
[4] Karakter Child and Adolescent Psychiatry University Centre,undefined
[5] University of Groningen,undefined
来源
关键词
ADHD; ODD; Risk factors; Comorbidity;
D O I
暂无
中图分类号
学科分类号
摘要
Oppositional defiant disorder (ODD) is highly prevalent in attention-deficit/hyperactivity disorder (ADHD). Individuals with both ADHD and ODD (ADHD + ODD) show a considerably worse prognosis compared with individuals with either ADHD or ODD. Therefore, identification of risk factors for ADHD + ODD is essential and may contribute to the development of (early) preventive interventions. Participants were matched for age, gender, and ADHD-subtype (diagnostic groups), and did not differ in IQ. Predictors included pre- and perinatal risk factors (pregnancy duration, birth weight, maternal smoking during pregnancy), transgenerational factors (parental ADHD; parental warmth and criticism in diagnostic groups), and postnatal risk factors (parental socioeconomic status [SES], adverse life events, deviant peer affiliation). Three models were assessed, investigating risk factors for ADHD-only versus controls (N = 86), ADHD + ODD versus controls (N = 86), and ADHD + ODD versus ADHD-only (N = 90). Adverse life events and parental ADHD were risk factors for both ADHD + ODD and ADHD-only, and more adverse life events were an even stronger risk factor for comorbid ODD compared with ADHD-only. For ADHD + ODD, but not ADHD-only, parental criticism, deviant peer affiliation, and parental SES acted as risk factors. Maternal smoking during pregnancy acted as minor risk factor for ADHD-only, while higher birth weight acted as minor risk factor for ADHD + ODD. No effects of age were present. Findings emphasise the importance of these factors in the development of comorbid ODD. The identified risk factors may prove to be essential in preventive interventions for comorbid ODD in ADHD, highlighting the need for parent-focused interventions to take these factors into account.
引用
收藏
页码:1155 / 1164
页数:9
相关论文
共 50 条
  • [1] Risk factors for comorbid oppositional defiant disorder in attention-deficit/hyperactivity disorder
    Noordermeer, Siri D. S.
    Luman, Marjolein
    Weeda, Wouter D.
    Buitelaar, Jan K.
    Richards, Jennifer S.
    Hartman, Catharina A.
    Hoekstra, Pieter J.
    Franke, Barbara
    Heslenfeld, Dirk J.
    Oosterlaan, Jaap
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2017, 26 (10) : 1155 - 1164
  • [3] EEG coherence in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder
    Barry, Robert J.
    Clarke, Adam R.
    McCarthy, Rory
    Selikowitz, Mark
    [J]. CLINICAL NEUROPHYSIOLOGY, 2007, 118 (02) : 356 - 362
  • [4] Neurocognitive Deficits in Attention-Deficit/Hyperactivity Disorder With and Without Comorbid Oppositional Defiant Disorder
    Noordermeer, Siri D. S.
    Luman, Marjolein
    Buitelaar, Jan K.
    Hartman, Catharina A.
    Hoekstra, Pieter J.
    Franke, Barbara
    Faraone, Stephen, V
    Heslenfeld, Dirk J.
    Oosterlaan, Jaap
    [J]. JOURNAL OF ATTENTION DISORDERS, 2020, 24 (09) : 1317 - 1329
  • [5] Children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: an EEG analysis
    Clarke, AR
    Barry, RJ
    McCarthy, R
    Selikowitz, M
    [J]. PSYCHIATRY RESEARCH, 2002, 111 (2-3) : 181 - 190
  • [6] Attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder
    Althoff, RR
    Rettew, DC
    Hudziak, JJ
    [J]. PSYCHIATRIC ANNALS, 2003, 33 (04) : 245 - 252
  • [7] Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder
    Daniel F. Connor
    [J]. Pediatric Drugs, 2015, 17 : 361 - 371
  • [8] Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder
    Connor, Daniel F.
    [J]. PEDIATRIC DRUGS, 2015, 17 (05) : 361 - 371
  • [9] Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder
    Newcorn, JH
    Spencer, TJ
    Biederman, J
    Milton, DR
    Michelson, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (03): : 240 - 248
  • [10] The influence of comorbid oppositional defiant disorder on white matter microstructure in attention-deficit/hyperactivity disorder
    Hanneke van Ewijk
    Siri D. S. Noordermeer
    Dirk J. Heslenfeld
    Marjolein Luman
    Catharina A. Hartman
    Pieter J. Hoekstra
    Stephen V. Faraone
    Barbara Franke
    Jan K. Buitelaar
    J. Oosterlaan
    [J]. European Child & Adolescent Psychiatry, 2016, 25 : 701 - 710